Cardiovascular safety, cancer and Jak-inhibitors: Differences to be highlighted

M Benucci, A Damiani, M Infantino, M Manfredi… - Pharmacological …, 2022 - Elsevier
Rheumatoid arthritis (RA) is a chronic inflammatory disease whose natural history leads to
articular and extra-articular damage. Both cardiovascular risk and malignancy risk results …
被引用次数：25 相关文章

Cardiovascular safety, cancer and Jak-inhibitors: Differences to be highlighted.

M Benucci, A Damiani, M Infantino… - Pharmacological …, 2022 - europepmc.org
Rheumatoid arthritis (RA) is a chronic inflammatory disease whose natural history leads to
articular and extra-articular damage. Both cardiovascular risk and malignancy risk results …

Cardiovascular safety, cancer and Jak-inhibitors: Differences to be highlighted

M Benucci, A Damiani, M Infantino… - Pharmacological …, 2022 - pubmed.ncbi.nlm.nih.gov
Rheumatoid arthritis (RA) is a chronic inflammatory disease whose natural history leads to
articular and extra-articular damage. Both cardiovascular risk and malignancy risk results …

Cardiovascular safety, cancer and Jak-inhibitors: Differences to be highlighted

M Benucci, A Damiani, M Infantino, M Manfredi… - PHARMACOLOGICAL …, 2022 - air.unimi.it
Rheumatoid arthritis (RA) is a chronic inflammatory disease whose natural history leads to
articular and extra-articular damage. Both cardiovascular risk and malignancy risk results …